471 related articles for article (PubMed ID: 14993144)
1. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.
Li JM; Wheatcroft S; Fan LM; Kearney MT; Shah AM
Circulation; 2004 Mar; 109(10):1307-13. PubMed ID: 14993144
[TBL] [Abstract][Full Text] [Related]
2. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla.
Chan SH; Hsu KS; Huang CC; Wang LL; Ou CC; Chan JY
Circ Res; 2005 Oct; 97(8):772-80. PubMed ID: 16151022
[TBL] [Abstract][Full Text] [Related]
3. Role of neuronal NO synthase in regulating vascular superoxide levels and mitogen-activated protein kinase phosphorylation.
Zhang GX; Kimura S; Murao K; Shimizu J; Matsuyoshi H; Takaki M
Cardiovasc Res; 2009 Feb; 81(2):389-99. PubMed ID: 18987049
[TBL] [Abstract][Full Text] [Related]
4. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
Touyz RM; Cruzado M; Tabet F; Yao G; Salomon S; Schiffrin EL
Can J Physiol Pharmacol; 2003 Feb; 81(2):159-67. PubMed ID: 12710530
[TBL] [Abstract][Full Text] [Related]
5. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells.
Touyz RM; Yao G; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):981-7. PubMed ID: 12663375
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent.
Widder J; Behr T; Fraccarollo D; Hu K; Galuppo P; Tas P; Angermann CE; Ertl G; Bauersachs J
Cardiovasc Res; 2004 Jul; 63(1):161-7. PubMed ID: 15194473
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of activated ERK1/2 and JNKs improves vascular function in mouse aortae in the absence of nitric oxide.
Bhattacharya I; Damjanović M; Dominguez AP; Haas E
Eur J Pharmacol; 2011 May; 658(1):22-7. PubMed ID: 20868664
[TBL] [Abstract][Full Text] [Related]
8. Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells.
Touyz RM; Yao G; Schiffrin EL
Can J Physiol Pharmacol; 2005 Jan; 83(1):91-7. PubMed ID: 15759055
[TBL] [Abstract][Full Text] [Related]
9. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4.
Li JM; Fan LM; Christie MR; Shah AM
Mol Cell Biol; 2005 Mar; 25(6):2320-30. PubMed ID: 15743827
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1.
Naito T; Masaki T; Nikolic-Paterson DJ; Tanji C; Yorioka N; Kohno N
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F278-87. PubMed ID: 14583433
[TBL] [Abstract][Full Text] [Related]
12. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
[TBL] [Abstract][Full Text] [Related]
13. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
[TBL] [Abstract][Full Text] [Related]
14. Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
Harrison CB; Drummond GR; Sobey CG; Selemidis S
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):429-34. PubMed ID: 19843095
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
16. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II.
Touyz RM; Yao G; Quinn MT; Pagano PJ; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):512-8. PubMed ID: 15618548
[TBL] [Abstract][Full Text] [Related]
17. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
[TBL] [Abstract][Full Text] [Related]
18. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase.
Qamirani E; Ren Y; Kuo L; Hein TW
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):995-1001. PubMed ID: 15718491
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
